TWD 120.0
(-1.23%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 238.76 Million TWD | -15.4% |
2022 | 266.16 Million TWD | 4.4% |
2021 | 254.94 Million TWD | 4.11% |
2020 | 244.87 Million TWD | 3.55% |
2019 | 236.46 Million TWD | 18.32% |
2018 | 199.84 Million TWD | 13.87% |
2017 | 175.5 Million TWD | -6.29% |
2016 | 187.27 Million TWD | 2.63% |
2015 | 182.48 Million TWD | 3.18% |
2014 | 176.84 Million TWD | 18.23% |
2013 | 149.58 Million TWD | 7.44% |
2012 | 139.21 Million TWD | 3.46% |
2011 | 134.55 Million TWD | 0.12% |
2010 | 134.39 Million TWD | 8.33% |
2009 | 124.06 Million TWD | 14.21% |
2008 | 108.62 Million TWD | 15.45% |
2007 | 94.08 Million TWD | 17.27% |
2006 | 80.22 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 62.89 Million TWD | 7.74% |
2024 Q1 | 61.46 Million TWD | 7.79% |
2023 Q1 | 55.93 Million TWD | -15.99% |
2023 Q2 | 59.09 Million TWD | 5.65% |
2023 FY | 225.17 Million TWD | -15.4% |
2023 Q4 | 57.02 Million TWD | -9.37% |
2023 Q3 | 62.91 Million TWD | 6.46% |
2022 Q2 | 64.69 Million TWD | -8.07% |
2022 Q4 | 66.58 Million TWD | 3.19% |
2022 Q1 | 70.36 Million TWD | 8.87% |
2022 FY | 266.16 Million TWD | 4.4% |
2022 Q3 | 64.52 Million TWD | -0.26% |
2021 Q4 | 64.63 Million TWD | 5.54% |
2021 Q1 | 67.27 Million TWD | 1.89% |
2021 FY | 254.94 Million TWD | 4.11% |
2021 Q2 | 61.78 Million TWD | -8.15% |
2021 Q3 | 61.24 Million TWD | -0.88% |
2020 FY | 244.87 Million TWD | 3.55% |
2020 Q1 | 59.48 Million TWD | -8.45% |
2020 Q4 | 66.02 Million TWD | 2.6% |
2020 Q3 | 64.35 Million TWD | 16.99% |
2020 Q2 | 55 Million TWD | -7.54% |
2019 FY | 236.46 Million TWD | 18.32% |
2019 Q2 | 58.91 Million TWD | 9.58% |
2019 Q1 | 53.76 Million TWD | -0.75% |
2019 Q4 | 64.98 Million TWD | 10.49% |
2019 Q3 | 58.81 Million TWD | -0.16% |
2018 FY | 199.84 Million TWD | 13.87% |
2018 Q3 | 50.97 Million TWD | 4.0% |
2018 Q4 | 54.17 Million TWD | 6.27% |
2018 Q1 | 45.69 Million TWD | 0.78% |
2018 Q2 | 49.01 Million TWD | 7.26% |
2017 Q4 | 45.34 Million TWD | -1.28% |
2017 Q1 | 40.54 Million TWD | -18.94% |
2017 Q3 | 45.92 Million TWD | 5.11% |
2017 FY | 175.5 Million TWD | -6.29% |
2017 Q2 | 43.69 Million TWD | 7.77% |
2016 Q2 | 47.64 Million TWD | -1.01% |
2016 Q3 | 41.49 Million TWD | -12.9% |
2016 Q4 | 50.01 Million TWD | 20.55% |
2016 FY | 187.27 Million TWD | 2.63% |
2016 Q1 | 48.12 Million TWD | -7.06% |
2015 FY | 182.48 Million TWD | 3.18% |
2015 Q1 | 46.03 Million TWD | -11.91% |
2015 Q4 | 51.78 Million TWD | 16.16% |
2015 Q2 | 40.08 Million TWD | -12.93% |
2015 Q3 | 44.57 Million TWD | 11.21% |
2014 Q4 | 52.26 Million TWD | 24.54% |
2014 FY | 176.84 Million TWD | 18.23% |
2014 Q3 | 41.96 Million TWD | -2.61% |
2014 Q2 | 43.08 Million TWD | 8.98% |
2014 Q1 | 39.53 Million TWD | -4.2% |
2013 Q4 | 41.27 Million TWD | 11.66% |
2013 FY | 149.58 Million TWD | 7.44% |
2013 Q1 | 34.99 Million TWD | -14.36% |
2013 Q2 | 36.34 Million TWD | 3.87% |
2013 Q3 | 36.96 Million TWD | 1.69% |
2012 Q2 | 31.77 Million TWD | -8.14% |
2012 Q1 | 34.59 Million TWD | -4.75% |
2012 Q3 | 31.83 Million TWD | 0.2% |
2012 FY | 139.21 Million TWD | 3.46% |
2012 Q4 | 40.86 Million TWD | 28.34% |
2011 Q2 | 33.41 Million TWD | -1.67% |
2011 Q1 | 33.97 Million TWD | 1.32% |
2011 FY | 134.55 Million TWD | 0.12% |
2011 Q3 | 30.84 Million TWD | -7.67% |
2011 Q4 | 36.31 Million TWD | 17.73% |
2010 Q4 | 33.53 Million TWD | -1.28% |
2010 Q3 | 33.97 Million TWD | -5.63% |
2010 Q2 | 36 Million TWD | 16.57% |
2010 Q1 | 30.88 Million TWD | 0.0% |
2010 FY | 134.39 Million TWD | 8.33% |
2009 FY | 124.06 Million TWD | 14.21% |
2008 FY | 108.62 Million TWD | 15.45% |
2007 FY | 94.08 Million TWD | 17.27% |
2006 FY | 80.22 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
St.Shine Optical Co.,Ltd. | 374.5 Million TWD | 36.246% |
Chi Sheng Pharma & Biotech Co., Ltd | 281.88 Million TWD | 15.3% |
Sunder Biomedical Tech. Co., Ltd. | 77.91 Million TWD | -206.442% |
BenQ Medical Technology Corporation | 978.46 Million TWD | 75.598% |
Pacific Hospital Supply Co., Ltd | 241.73 Million TWD | 1.229% |
Unicon Optical Co., Ltd. | 215.77 Million TWD | -10.651% |
Formosa Optical Technology Co.,Ltd. | 2.05 Billion TWD | 88.376% |
Medeon Biodesign, Inc. | 774.36 Million TWD | 69.167% |
Concord Medical Co., Ltd. | 102.14 Million TWD | -133.743% |
Crystalvue Medical Corporation | 142.58 Million TWD | -67.451% |
Perfect Medical Industry Co., Ltd. | 200.55 Million TWD | -19.049% |
ICARES Medicus, Inc. | 482.4 Million TWD | 50.506% |
Lagis Enterprise Co., Ltd. | 141.78 Million TWD | -68.397% |
Amed Co., Ltd. | 385.94 Million TWD | 38.136% |